National Health Investors Inc. (NYSE:NHI)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $78.88, but opened at $79.06. National Health Investors shares last traded at $79.64, with a volume of 81,820 shares.

Several equities analysts have weighed in on the stock. Zacks Investment Research upgraded shares of National Health Investors from a “hold” rating to a “buy” rating and set a $86.00 price objective on the stock in a research report on Wednesday, July 27th. Mizuho lifted their price objective on shares of National Health Investors from $66.00 to $77.00 and gave the stock a “neutral” rating in a research report on Monday. Cantor Fitzgerald assumed coverage on shares of National Health Investors in a research report on Thursday, June 23rd. They set a “hold” rating and a $70.00 price objective on the stock. Finally, JMP Securities reiterated a “hold” rating on shares of National Health Investors in a research report on Saturday, June 4th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company’s stock. National Health Investors has a consensus rating of “Hold” and an average target price of $72.50.

The firm has a market capitalization of $3.12 billion and a price-to-earnings ratio of 18.35. The stock’s 50 day moving average is $76.49 and its 200-day moving average is $68.54.

National Health Investors (NYSE:NHI) last announced its quarterly earnings data on Friday, August 5th. The real estate investment trust reported $1.22 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.21 by $0.01. The business earned $61.20 million during the quarter, compared to analyst estimates of $58.08 million. During the same quarter in the prior year, the company earned $1.17 earnings per share. The company’s quarterly revenue was up 8.7% on a year-over-year basis. On average, equities research analysts forecast that National Health Investors Inc. will post $4.87 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 10th. Investors of record on Friday, September 30th will be issued a $0.90 dividend. The ex-dividend date is Wednesday, September 28th. This represents a $3.60 annualized dividend and a yield of 4.52%.

In related news, Director Robert A. Mccabe, Jr. sold 1,250 shares of the stock in a transaction that occurred on Monday, June 13th. The shares were sold at an average price of $71.61, for a total value of $89,512.50. Following the transaction, the director now directly owns 9,736 shares in the company, valued at $697,194.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Kristin Sallee Gaines sold 4,044 shares of the stock in a transaction that occurred on Tuesday, June 28th. The shares were sold at an average price of $73.71, for a total transaction of $298,083.24. Following the completion of the transaction, the insider now owns 53,089 shares in the company, valued at $3,913,190.19. The disclosure for this sale can be found here.

A number of large investors have recently modified their holdings of the stock. New York State Common Retirement Fund increased its stake in shares of National Health Investors by 2.9% in the fourth quarter. New York State Common Retirement Fund now owns 35,300 shares of the real estate investment trust’s stock valued at $2,149,000 after buying an additional 1,000 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of National Health Investors by 7.0% in the fourth quarter. Vanguard Group Inc. now owns 5,098,352 shares of the real estate investment trust’s stock valued at $310,337,000 after buying an additional 335,445 shares during the last quarter. Schroder Investment Management Group purchased a new stake in shares of National Health Investors during the fourth quarter valued at approximately $4,973,000. Finally, Westfield Capital Management Co. LP increased its stake in shares of National Health Investors by 81.4% in the fourth quarter. Westfield Capital Management Co. LP now owns 436,425 shares of the real estate investment trust’s stock valued at $26,565,000 after buying an additional 195,807 shares during the last quarter.

National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.